These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6656463)

  • 1. [Monoclonal origin of chronic myeloproliferative syndromes].
    Cervantes F
    Med Clin (Barc); 1983 Dec; 81(19):853-5. PubMed ID: 6656463
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic myeloproliferative disorders: molecular markers and pathogenesis.
    Skoda RC
    Hematol J; 2004; 5 Suppl 3():S122-5. PubMed ID: 15190293
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic granulocytic leukemia as a proliferative panmyelopathy of a clonal nature].
    Sánchez Fayos J; Lasierra Cirujeda J
    Sangre (Barc); 1984; 29(4-B):491-501. PubMed ID: 6393378
    [No Abstract]   [Full Text] [Related]  

  • 4. Gain of 9p due to an unbalanced rearrangement der(9;18): a recurrent clonal abnormality in chronic myeloproliferative disorders.
    Bacher U; Haferlach T; Schoch C
    Cancer Genet Cytogenet; 2005 Jul; 160(2):179-83. PubMed ID: 15993276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome abnormalities in the myeloproliferative disorders.
    Dewald GW; Wright PI
    Semin Oncol; 1995 Aug; 22(4):341-54. PubMed ID: 7638632
    [No Abstract]   [Full Text] [Related]  

  • 6. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.
    Richter K; Pinto do O P; Hägglund AC; Wahlin A; Carlsson L
    Haematologica; 2003 Dec; 88(12):1336-47. PubMed ID: 14687986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of secondary hematologic disorders: preMDS-->MDS-->sAML.
    Preisler HD
    Cancer Treat Res; 2001; 108():185-230. PubMed ID: 11702600
    [No Abstract]   [Full Text] [Related]  

  • 8. Not just clonal expansion of hematopoietic cells, but also activation of their progeny in the pathogenesis of myeloproliferative disorders.
    Cazzola M; Passamonti F
    Haematologica; 2006 Feb; 91(2):159. PubMed ID: 16461298
    [No Abstract]   [Full Text] [Related]  

  • 9. Neoplasms of the hematopoietic stem cell.
    Adamson JW
    Prog Clin Biol Res; 1985; 184():393-402. PubMed ID: 4048194
    [No Abstract]   [Full Text] [Related]  

  • 10. [Histopathology and molecular pathology of chronic myeloproliferative disorders].
    Kreipe HH
    Veroff Pathol; 1993; 141():1-158. PubMed ID: 8372486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular mechanisms of myeloproliferative disorders.
    Ogawa M
    Br J Haematol; 1984 Dec; 58(4):563-5. PubMed ID: 6518132
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytogenetic studies in Philadelphia chromosome-negative myeloproliferative disorders, particularly polycythaemia rubra vera.
    Lawler SD
    Clin Haematol; 1980 Feb; 9(1):159-74. PubMed ID: 6768481
    [No Abstract]   [Full Text] [Related]  

  • 13. Clonal nature of hematopoietic stem cell disorders.
    Bergamaschi G
    Haematologica; 2004 Jan; 89(1):5-6. PubMed ID: 14754598
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic myeloproliferative diseases with the t(5;12)(q33;p13): clonal evolution is associated with blast crisis.
    Han X; Medeiros LJ; Abruzzo LV; Jones D; Lin P
    Am J Clin Pathol; 2006 Jan; 125(1):49-56. PubMed ID: 16482991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of abnormal clones in single colonies from a patient with idiopathic myelofibrosis.
    Suda T; Sato Y; Suda J; Kubota K; Saito M; Miura Y
    Prog Clin Biol Res; 1986; 215():355-9. PubMed ID: 3725786
    [No Abstract]   [Full Text] [Related]  

  • 16. Clonal analysis of hematologic malignancies using Mediterranean G6PD mosaicism.
    Canepa L; Melani C; Broccia G; Meloni T; Miglino M; Ferraris AM; Gaetani GF
    Haematologica; 1988; 73(5):343-6. PubMed ID: 3143630
    [No Abstract]   [Full Text] [Related]  

  • 17. Primitive hematopoietic stem cells shows a polyclonal pattern in myelodysplastic syndromes.
    Guidetti F; Grazioli S; Capelli F; Marini C; Gallicchio M; De Micheli D; Castello L; Sainaghi PP; Fra GP; Saglio G; Avanzi GC
    Haematologica; 2004 Jan; 89(1):21-8. PubMed ID: 14754602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: clinical implications.
    Panani AD
    Cancer Lett; 2007 Sep; 255(1):12-25. PubMed ID: 17383090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic granulocytic leukemia (Ph+): among yesterday's myeloproliferative syndromes, today's chronic myeloid leukemias, and tomorrow's mature-element monocellular myelopathies].
    Sánchez Fayos J; Prieto E; Chica Gullón E
    Sangre (Barc); 1998 Apr; 43(2):121-6. PubMed ID: 9656773
    [No Abstract]   [Full Text] [Related]  

  • 20. [Unclassified chronic myeloproliferative Ph(-); i(17q); +8 syndrome with mixed myelo-megakaryoblastic crisis--case report].
    Mariańska B; Apel D; Seferyńska I; Maj S
    Acta Haematol Pol; 1996; 27(1):85-8. PubMed ID: 8629449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.